The GLP-1 Megatrend (1 of 4): The Mechanistic Blind Spot No One Wants to Admit Published in Biomedical Research India Ambler and 2 others The rapid ascent of GLP-1based therapies has created one of the most consequential shifts in modern medicine, reshaping clinical practice across obesity, diabetes, cardiometabolic disease, liver pathology, and even neurodegeneration
Sep 10 2019;7(9)doi:10.3390/medsci7090095
1 Sharing your updated medication list with your healthcare provider helps ensure safe and effective use
A provider can help determine if you are a better candidate for glutathione, Vitamin B12, or other metabolic boosters
In the CAD group, the expression level of GLP-1R_M1 (GLP-1 macrophages M1) was positively correlated with triglycerides (TG) and GLP-1R on the cell membrane of total, M1, and M2 macrophages was lower than that of the HC group
Acknowledgements This study was supported by the National Natural Science Foundation of China (81800768 and 81800723) and Beijing Natural Science Foundation (7212055)